Abstract
The model of experimental autoimmune uveitis (EAU) in mice and in rats is described. EAU targets immunologically privileged retinal antigens and serves as a model of autoimmune uveitis in humans as well as a model for autoimmunity in a more general sense. EAU is a well-characterized, robust, and reproducible model that is easily followed and quantitated. It is inducible with synthetic peptides derived from retinal autoantigens in commonly available strains of rats and mice. The ability to induce EAU in various gene-manipulated, including HLA-transgenic, mouse strains makes the EAU model suitable for the study of basic mechanisms as well as in clinically relevant interventions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Caspi RR (1989) Basic mechanisms in immune-mediated uveitic disease. In: Lightman SL (ed) Immunology of eye disease, Vol. Ch. 5. Kluwer Academic Publishers, Lancaster, UK, pp 61–86
Caspi RR, Roberge FG, McAllister CG, el Saied M, Kuwabara T, Gery I, Hanna E, Nussenblatt RB (1986) T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. J Immunol 136:928–933
Gery I, Robinson WG Jr, Shichi H, El-Saied M, Mochizuki M, Nussenblatt RB, Williams RM (1985) Differences in susceptibility to experimental autoimmune uveitis among rats of various strains. In: Chandler JW, O’Conner GR (eds) Advances in immunology and immunopathology of the eye (Proceedings of the third international symposium on immunology and immunopathology of the eye), Vol. Ch. 59. Masson Publishing, NY, pp 242–245
Nussenblatt RB, Whitcup SM, Palestine AG (1996) Uveitis: fundamentals and clinical practice, 2nd edn. Mosby - Year Book, Inc., St. Louis, MO
Gery I, Mochizuki M, Nussenblatt RB (1986) Retinal specific antigens and immunopathogenic processes they provoke. Prog Retinal Res 5:75–109
Sanui H, Redmond TM, Kotake S, Wiggert B, Hu LH, Margalit H, Berzofsky JA, Chader GJ, Gery I (1989) Identification of an immunodominant and highly immunopathogenic determinant in the retinal interphotoreceptor retinoid-binding protein (IRBP). J Exp Med 169:1947–1960
Applebury ML, Hargrave PA (1986) Molecular biology of the visual pigments. Vision Res 26:1881–1895
Borst DE, Redmond TM, Elser JE, Gonda MA, Wiggert B, Chader GJ, Nickerson JM (1989) Interphotoreceptor retinoid-binding protein. Gene characterization, protein repeat structure, and its evolution. J Biol Chem 264:1115–1123
Mirshahi M, Boucheix C, Collenot G, Thillaye B, Faure JP (1985) Retinal S-antigen epitopes in vertebrate and invertebrate photoreceptors. Invest Ophthalmol Vis Sci 26:1016–1021
Pfister C, Chabre M, Plouet J, Van Tuyen V, De Kozak Y, Faure JP, Kühn H (1985) Retinal S antigen identified as the 48 K protein regulating light-dependent phosphodiesterase in rods. Science 228:891–893
Schalken JJ, Winkens HJ, van Vugt AH, Bovëe-Geurts PH, de Grip WJ, Broekhuyse RM (1988) Rhodopsin-induced experimental autoimmune uveoretinitis: dose-dependent clinicopathological features. Exp Eye Res 47:135–145
Hirose S, Ogasawara K, Natori T, Sasamoto Y, Ohno S, Matsuda H, Onoe K (1991) Regulation of experimental autoimmune uveitis in rats–separation of MHC and non-MHC gene effects. Clin Exp Immunol 86:419–425
Caspi RR, Grubbs BG, Chan CC, Chader GJ, Wiggert B (1992) Genetic control of susceptibility to experimental autoimmune uveoretinitis in the mouse model: Concomitant regulation by MHC and non-MHC genes. J Immunol 148:2384–2389
Luger D, Silver PB, Tang J, Cua D, Chen Z, Iwakura Y, Bowman EP, Sgambellone NM, Chan CC, Caspi RR (2008) Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 205:799–810
Caspi RR, Silver PB, Chan CC, Sun B, Agarwal RK, Wells J, Oddo S, Fujino Y, Najafian F, Wilder RL (1996) Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response. J Immunol 157:2668–2675
Sun B, Rizzo LV, Sun SH, Chan CC, Wiggert B, Wilder RL, Caspi RR (1997) Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T helper-1-like or a T helper-2-like response. J Immunol 159:1004–1011
Rizzo LV, Xu H, Chan CC, Wiggert B, Caspi RR (1998) IL-10 has a protective role in experimental autoimmune uveoretinitis. Int Immunol 10:807–814
Egwuagu CE, Charukamnoetkanok P, Gery I (1997) Thymic expression of autoantigens correlates with resistance to autoimmune disease. J Immunol 159:3109–3112
Caspi RR, Chan C-C, Fujino Y, Oddo S, Najafian F, Bahmanyar S, Heremans H, Wilder RL, Wiggert B (1992) Genetic factors in susceptibility and resistance to experimental autoimmune uveoretinitis. Curr Eye Res 11(suppl):81–86
Mochizuki M, Kuwabara T, Chan CC, Nussenblatt RB, Metcalfe DD, Gery I (1984) An association between susceptibility to experimental autoimmune uveitis and choroidal mast cell numbers. J Immunol 133:1699–1701
Pennesi G, Caspi RR (2002) Genetic control of susceptibility in clinical and experimental uveitis. Int Rev Immunol 21:67–88
Agarwal RK, Chan CC, Wiggert B, Caspi RR (1999) Pregnancy ameliorates induction and expression of experimental autoimmune uveitis. J Immunol 162:2648–2654
Caspi RR, Chan CC, Grubbs BG, Silver PB, Wiggert B, Parsa CF, Bahmanyar S, Billiau A, Heremans H (1994) Endogenous systemic IFN-gamma has a protective role against ocular autoimmunity in mice. J Immunol 152:890–899
Silver PB, Chan CC, Wiggert B, Caspi RR (1999) The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment. Invest Ophthalmol Vis Sci 40:2898–2905
Arimoto H, Tanuma N, Jee Y, Miyazawa T, Shima K, Matsumoto Y (2000) Analysis of experimental autoimmune encephalomyelitis induced in F344 rats by pertussis toxin administration. J Neuroimmunol 104:15–21
Ma RZ, Gao J, Meeker ND, Fillmore PD, Tung KS, Watanabe T, Zachary JF, Offner H, Blankenhorn EP, Teuscher C (2002) Identification of Bphs, an autoimmune disease locus, as histamine receptor H1. Science 297:620–623
Sudweeks JD, Todd JA, Blankenhorn EP, Wardell BB, Woodward SR, Meeker ND, Estes SS, Teuscher C (1993) Locus controlling Bordetella pertussis-induced histamine sensitization (Bphs), an autoimmune disease-susceptibility gene, maps distal to T-cell receptor beta-chain gene on mouse chromosome 6. Proc Natl Acad Sci U S A 90:3700–3704
Chen X, Howard OM, Oppenheim JJ (2007) Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells. J Immunol 178:6123–6129
Su SB, Silver PB, Wang P, Chan CC, Caspi RR (2003) Dissociating the enhancing and inhibitory effects of pertussis toxin on autoimmune disease. J Immunol 171:2314–2319
Su SB, Silver PB, Zhang M, Chan CC, Caspi RR (2001) Pertussis toxin inhibits induction of tissue-specific autoimmune disease by disrupting G protein-coupled signals. J Immunol 167:250–256
Agarwal RK, Sun SH, Su SB, Chan CC, Caspi RR (2002) Pertussis toxin alters the innate and the adaptive immune responses in a pertussis-dependent model of autoimmunity. J Neuroimmunol 129:133–140
Caspi RR (1993) Immunogenetic aspects of clinical and experimental uveitis. Reg Immunol 4:321–330
Caspi RR, Roberge FG, Chan CC, Wiggert B, Chader GJ, Rozenszajn LA, Lando Z, Nussenblatt RB (1988) A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J Immunol 140:1490–1495
Faure JP (1980) Autoimmunity and the retina. Curr Top Eye Res 2:215–301
Aronson SB, Hogan MJ, Zweigart P (1963) Homoimmune uveitis in the guinea-pig. I. General concepts of auto- and homoimmunity, methods and manifestations. Arch Ophthalmol 69:105–109
Aronson SB, Hogan MJ, Zweigart P (1963) Homoimmune uveitis in the guinea-pig. III. Histopathologic manifestations of the disease. Arch Ophthalmol 69:208–219
Aronson SB, Hogan MJ, Zweigart P (1963) Homoimmune uveitis in the guinea-pig. II. Clinical manifestations. Arch Ophthalmol 69:203–207
Wacker WB, Kalsow CM (1973) Autoimmune uveo-retinitis in the rat sensitized with retina photoreceptor cell antigen. Int Arch Allergy Appl Immunol 45:582–592
de Kozak Y, Sakai J, Thillaye B, Faure JP (1981) S antigen-induced experimental autoimmune uveo-retinitis in rats. Curr Eye Res 1:327–337
Gery I, Wiggert B, Redmond TM, Kuwabara T, Crawford MA, Vistica BP, Chader GJ (1986) Uveoretinitis and pinealitis induced by immunization with interphotoreceptor retinoid-binding protein. Invest Ophthalmol Vis Sci 27:1296–1300
Caspi R (1996) Experimental autoimmune uveoretinitis (EAU) – mouse and rat. In: Kruisbeek A, Margulies D, Shevach E, Strober W (eds) Current protocols in immunology, Vol. January. Wiley, New York, NY, USA, pp Unit 15.16.11–Unit 15.16.18
Caspi RR (1994) Experimental autoimmune uveoretinitis: rat and mouse. In: Cohen I, Miller A (eds) Autoimmune disease models: a guidebook. Academic, New York
Mozayeni RM, Chan CC, Grubbs BE, Stober DI, Wiggert B, Chader GJ, Nussenblatt RB, Caspi RR (1995) Alternative methods of immunization for the induction of experimental autoimmune uveoretinitis (EAU) in rodent models: a comparison. Ocul Immunol Inflamm 3:81–87
Mochizuki M, Kuwabara T, McAllister C, Nussenblatt RB, Gery I (1985) Adoptive transfer of experimental autoimmune uveoretinitis in rats. Immunopathogenic mechanisms and histologic features. Invest Ophthalmol Vis Sci 26:1–9
Beraud E, Kotake S, Caspi RR, Oddo SM, Chan CC, Gery I, Nussenblatt RB (1992) Control of experimental autoimmune uveoretinitis by low dose T cell vaccination. Cell Immunol 140:112–122
Avichezer D, Silver PB, Chan CC, Wiggert B, Caspi RR (2000) Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype. Invest Ophthalmol Vis Sci 41:127–131
Namba K, Ogasawara K, Kitaichi N, Matsuki N, Takahashi A, Sasamoto Y, Kotake S, Matsuda H, Iwabuchi K, Ohno S, Onoe K (1998) Identification of a peptide inducing experimental autoimmune uveoretinitis (EAU) in H-2Ak-carrying mice. Clin Exp Immunol 111:442–449
Silver PB, Rizzo LV, Chan CC, Donoso LA, Wiggert B, Caspi RR (1995) Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype. Invest Ophthalmol Vis Sci 36:946–954
Cortes LM, Avichezer D, Silver PB, Luger D, Mattapallil MJ, Chan CC, Caspi RR (2008) Inhibitory peptide analogs derived from a major uveitogenic epitope protect from antiretinal autoimmunity by inducing type 2 and regulatory T cells. J Leukoc Biol 84:577–585
Szpak Y, Vieville JC, Tabary T, Naud MC, Chopin M, Edelson C, Cohen JH, Dausset J, de Kozak Y, Pla M (2001) Spontaneous retinopathy in HLA-A29 transgenic mice. Proc Natl Acad Sci U S A 98:2572–2576
Pennesi G, Mattapallil MJ, Sun SH, Avichezer D, Silver PB, Karabekian Z, David CS, Hargrave PA, McDowell JH, Smith WC, Wiggert B, Donoso LA, Chan CC, Caspi RR (2003) A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice. J Clin Invest 111:1171–1180
Axtell RC, de Jong BA, Boniface K, van der Voort LF, Bhat R, De Sarno P, Naves R, Han M, Zhong F, Castellanos JG, Mair R, Christakos A, Kolkowitz I, Katz L, Killestein J, Polman CH, de Waal MR, Steinman L, Raman C (2010) T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat Med 16:406–412
Domingues HS, Mues M, Lassmann H, Wekerle H, Krishnamoorthy G (2010) Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. PLoS One 5:e15531
Tang J, Zhu W, Silver PB, Su SB, Chan CC, Caspi RR (2007) Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: initial encounter with autoantigen defines disease phenotype. J Immunol 178:5578–5587
Knapp JE, Liu D (2004) Hydrodynamic delivery of DNA. Methods Mol Biol 245:245–250
Chan CC, Caspi RR, Ni M, Leake WC, Wiggert B, Chader GJ, Nussenblatt RB (1990) Pathology of experimental autoimmune uveoretinitis in mice. J Autoimmun 3:247–255
Bjorck P (2001) Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood 98:3520–3526
Vremec D, Pooley J, Hochrein H, Wu L, Shortman K (2000) CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J Immunol 164:2978–2986
Donoso LA, Yamaki K, Merryman CF, Shinohara T, Yue S, Sery TW (1988) Human S-antigen: characterization of uveitopathogenic sites. Curr Eye Res 7:1077–1085
Singh VK, Nussenblatt RB, Donoso LA, Yamaki K, Chan CC, Shinohara T (1988) Identification of a uveitopathogenic and lymphocyte proliferation site in bovine S-antigen. Cell Immunol 115:413–419
Donoso LA, Merryman CF, Sery TW, Shinohara T, Dietzschold B, Smith A, Kalsow CM (1987) S-antigen: characterization of a pathogenic epitope which mediates experimental autoimmune uveitis and pinealitis in Lewis rats. Curr Eye Res 6:1151–1159
Kotake S, Redmond TM, Wiggert B, Vistica B, Sanui H, Chader GJ, Gery I (1991) Unusual immunologic properties of the uveitogenic interphotoreceptor retinoid-binding protein-derived peptide R23. Invest Ophthalmol Vis Sci 32:2058–2064
Sanui H, Redmond TM, Hu LH, Kuwabara T, Margalit H, Cornette JL, Wiggert B, Chader GJ, Gery I (1988) Synthetic peptides derived from IRBP induce EAU and EAP in Lewis rats. Curr Eye Res 7:727–735
Kotake S, de Smet MD, Wiggert B, Redmond TM, Chader GJ, Gery I (1991) Analysis of the pivotal residues of the immunodominant and highly uveitogenic determinant of interphotoreceptor retinoid-binding protein. J Immunol 146:2995–3001
de Smet MD, Bitar G, Roberge FG, Gery I, Nussenblatt RB (1993) Human S-Antigen: Presence of multiple immunogenic and Âimmunopathogenic sites in the Lewis rat. J Autoimmun 6:587–599
Merryman CF, Donoso LA, Zhang XM, Heber-Katz E, Gregerson DS (1991) Characterization of a new, potent, immunopathogenic epitope in S-antigen that elicits T cells expressing V beta 8 and V alpha 2-like genes. J Immunol 146:75–80
Gregerson DS, Merryman CF, Obritsch WF, Donoso LA (1990) Identification of a potent new pathogenic site in human retinal S-antigen which induces experimental autoimmune uveoretinitis in LEW rats. Cell Immunol 128:209–219
Donoso LA, Merryman CF, Sery T, Sanders R, Vrabec T, Fong SL (1989) Human interstitial retinoid binding protein. A potent uveitopathogenic agent for the induction of experimental autoimmune uveitis. J Immunol 143:79–83
Horai R, Caspi RR (eds) (2010) Retinal inflammation: uveitis/uveoretinitis. Animal models for retinal diseases, Neuromethods, vol 46. Humana, New York, NY
Mattapallil MJ, Wawrousek EF, Chan CC, Zhao H, Roychoudhury J, Ferguson TA, Caspi RR (2012) The rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes. Invest Ophthalmol Vis Sci. (in press)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this protocol
Cite this protocol
Agarwal, R.K., Silver, P.B., Caspi, R.R. (2012). Rodent Models of Experimental Autoimmune Uveitis. In: Perl, A. (eds) Autoimmunity. Methods in Molecular Biology, vol 900. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-720-4_22
Download citation
DOI: https://doi.org/10.1007/978-1-60761-720-4_22
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-719-8
Online ISBN: 978-1-60761-720-4
eBook Packages: Springer Protocols